UNICHEM LABORATORIES
Quarterly Results Analysis [Dec2023]
UNICHEM LABORATORIES Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 Audited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹434 Cr | ₹416 Cr | ₹423 Cr | ₹402 Cr | ₹302 Cr | ₹329 Cr | ₹310 Cr | ₹370 Cr |
Expenses | ₹396 Cr | ₹407 Cr | ₹395 Cr | ₹386 Cr | ₹345 Cr | ₹347 Cr | ₹311 Cr | ₹302 Cr |
Operating Income | ₹38 Cr | ₹9 Cr | ₹28 Cr | ₹16 Cr | ₹-43 Cr | ₹-18 Cr | ₹-1 Cr | ₹68 Cr |
Other Income | ₹11 Cr | ₹6 Cr | ₹9 Cr | ₹5 Cr | ₹16 Cr | ₹9 Cr | ₹8 Cr | ₹14 Cr |
Interest | ₹6 Cr | ₹7 Cr | ₹6 Cr | ₹6 Cr | ₹4 Cr | ₹5 Cr | ₹3 Cr | ₹2 Cr |
Depreciation | ₹28 Cr | ₹29 Cr | ₹29 Cr | ₹30 Cr | ₹31 Cr | ₹28 Cr | ₹25 Cr | ₹23 Cr |
Profit Before Tax | ₹84 Cr | ₹-22 Cr | ₹2 Cr | ₹-47 Cr | ₹-61 Cr | ₹-47 Cr | ₹-21 Cr | ₹58 Cr |
Profit After Tax | ₹84 Cr | ₹-24 Cr | ₹-1 Cr | ₹-44 Cr | ₹-64 Cr | ₹-71 Cr | ₹-23 Cr | ₹71 Cr |
EPS | ₹11.93 | ₹-3.48 | ₹-0.09 | ₹-6.29 | ₹-9.08 | ₹-10.04 | ₹-3.32 | ₹10.15 |
Industry Peers & Returns | 1W | 1M | 1Y |
UNICHEM LABORATORIES | -4.6% | -9.7% | 75.2% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
UNICHEM LABORATORIES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 4.51 % |
Y-o-Y | 43.60 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹434 Cr | 4.51 | |
Sep2023 | ₹416 Cr | -1.79 | |
Jun2023 | ₹423 Cr | 5.24 | |
Mar2023 | ₹402 Cr | 32.93 | |
Dec2022 | ₹302 Cr | -8.01 | |
Sep2022 | ₹329 Cr | 6.20 | |
Jun2022 | ₹310 Cr | -16.31 | |
Mar2022 | ₹370 Cr | - |
UNICHEM LABORATORIES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 334.97 % |
Y-o-Y | Positive |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹38 Cr | 334.97 | |
Sep2023 | ₹9 Cr | -68.72 | |
Jun2023 | ₹28 Cr | 69.98 | |
Mar2023 | ₹16 Cr | Positive | |
Dec2022 | ₹-43 Cr | Negative | |
Sep2022 | ₹-18 Cr | Negative | |
Jun2022 | ₹-1 Cr | Negative | |
Mar2022 | ₹68 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 315.64 % |
Y-o-Y | Positive |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 8.77% | 315.64 | |
Sep2023 | 2.11% | -68.13 | |
Jun2023 | 6.62% | 61.46 | |
Mar2023 | 4.1% | Positive | |
Dec2022 | -14.14% | Negative | |
Sep2022 | -5.57% | Negative | |
Jun2022 | -0.31% | Negative | |
Mar2022 | 18.5% | - |
UNICHEM LABORATORIES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | Positive |
Y-o-Y | Positive |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹84 Cr | Positive | |
Sep2023 | ₹-24 Cr | Negative | |
Jun2023 | ₹-1 Cr | Negative | |
Mar2023 | ₹-44 Cr | Negative | |
Dec2022 | ₹-64 Cr | Negative | |
Sep2022 | ₹-71 Cr | Negative | |
Jun2022 | ₹-23 Cr | Negative | |
Mar2022 | ₹71 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | Positive |
Y-o-Y | Positive |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 19.34 % | Positive | |
Sep2023 | -5.89 % | Negative | |
Jun2023 | -0.16 % | Negative | |
Mar2023 | -11.01 % | Negative | |
Dec2022 | -21.13 % | Negative | |
Sep2022 | -21.49 % | Negative | |
Jun2022 | -7.55 % | Negative | |
Mar2022 | 19.32 % | - |
UNICHEM LABORATORIES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | Positive |
Y-o-Y | Positive |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹11.93 | Positive | |
Sep2023 | ₹-3.48 | Negative | |
Jun2023 | ₹-0.09 | Negative | |
Mar2023 | ₹-6.29 | Negative | |
Dec2022 | ₹-9.08 | Negative | |
Sep2022 | ₹-10.04 | Negative | |
Jun2022 | ₹-3.32 | Negative | |
Mar2022 | ₹10.15 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD